title: Seroprevalences of herpes simplex virus type 2, five oncogenic human papillomaviruses, and Chlamydia trachomatis in Katowice, Poland.
abstract: Herpes simplex virus type 2 (HSV-2), human papillomaviruses (HPVs), and Chlamydia trachomatis are the most common pathogens causing sexually transmitted infections (STIs). There is limited information about the prevalences of these STIs in Poland. Here, we estimated the occurrence of immunoglobulin G (IgG) antibodies against HSV-2, HPV, and C. trachomatis in 199 blood donors and 110 patients of both genders attending an STI clinic in Katowice in southern Poland. The seroprevalences of HSV-2 were 5% for blood donors and 14% in the STI cohort. The seroprevalences of the five potentially oncogenic HPV types 16, 18, 31, 35, and 51 were 15%, 7%, 5%, 5%, and 17%, respectively, in blood donors and 37%, 8%, 12%, 5%, and 21%, respectively, in the STI cohort. The majority of HPV-infected individuals showed antibodies against more than one type, i.e., had been infected with multiple HPV types. Anti-C. trachomatis IgG antibodies were detected in 6% of blood donors and 13% of individuals attending the STI clinic. The relatively high prevalence of HPV-51 may have implications for future vaccine programs, as the newly introduced HPV vaccines are based on the potentially oncogenic HPV types 16 and 18.
authors.affiliation: Department of Virology, Institute of Biomedicine, Sahlgrenska Academy, Göteborg University, S-413 46 Göteborg, Sweden. staffan.gorander@gu.se
authors.forename: Staffan
authors.initials: S
authors.lastname: Görander
authors.forename: Teresa
authors.initials: T
authors.lastname: Lagergård
authors.forename: Malgorzata
authors.initials: M
authors.lastname: Romanik
authors.forename: Raphael P
authors.initials: RP
authors.lastname: Viscidi
authors.forename: Gayane
authors.initials: G
authors.lastname: Martirosian
authors.forename: Jan-Ake
authors.initials: JA
authors.lastname: Liljeqvist
mesh_terms: D000328:Adult; D002690:Chlamydia Infections / Q000097:blood / Q000453:epidemiology* / Q000382:microbiology; D002692:Chlamydia trachomatis / Q000302:isolation & purification*; D005260:Female; D006558:Herpes Genitalis / Q000097:blood / Q000453:epidemiology* / Q000821:virology; D018258:Herpesvirus 2, Human / Q000302:isolation & purification*; D006801:Humans; D008297:Male; D008875:Middle Aged; D027383:Papillomaviridae / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000097:blood / Q000453:epidemiology* / Q000821:virology; D011044:Poland / Q000453:epidemiology; D016036:Seroepidemiologic Studies